Chanice Henry | 09/28/2015
“Changes in lifestyles and healthcare systems, and increasing demand for drugs at reduced prices, has led to the development of facilities that can produce more than one product, offering flexibility and scalability.” (4) Single use systems, which are utilized within upstream and downstream processing, can simplify the path to market via the reduction of sterilisation time, swifter set up times, lower cross contamination levels and lower operating costs.According to a recent study, the global si...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More